Angiotensin-converting enzyme inhibitors enhance the effect of cyclooxygenase inhibitors on breast cancer: a nationwide case-control study.

MLA

Lee HH, et al. “Angiotensin-Converting Enzyme Inhibitors Enhance the Effect of Cyclooxygenase Inhibitors on Breast Cancer: A Nationwide Case-Control Study.” Journal of Hypertension, vol. 30, no. 12, Dec. 2012, pp. 2432–39. EBSCOhost, https://doi.org/10.1097/HJH.0b013e328358d42f.

APA

Lee HH, Tsan YT, Ho WC, Lin MH, Lee CH, Tseng CD, Guo YL, Wang JD, Chen PC, & Health Data Analysis in Taiwan (hDATa) Research Group. (2012). Angiotensin-converting enzyme inhibitors enhance the effect of cyclooxygenase inhibitors on breast cancer: a nationwide case-control study. Journal of Hypertension, 30(12), 2432–2439. https://doi.org/10.1097/HJH.0b013e328358d42f

Chicago

Lee HH, Tsan YT, Ho WC, Lin MH, Lee CH, Tseng CD, Guo YL, Wang JD, Chen PC, and Health Data Analysis in Taiwan (hDATa) Research Group. 2012. “Angiotensin-Converting Enzyme Inhibitors Enhance the Effect of Cyclooxygenase Inhibitors on Breast Cancer: A Nationwide Case-Control Study.” Journal of Hypertension 30 (12): 2432–39. doi:10.1097/HJH.0b013e328358d42f.